Clinical context
15%
semaglutide avg
20%+
tirzepatide avg
Published trial context. Individual results vary.
For people who do their own research
If hype makes you suspicious, start with the mechanism: appetite signaling, slower gastric emptying, trial averages, and the flat-rate options available after the quiz.
88%
Results by wk 4
−17%
Avg body wt
4.8★
Patient rating
Start with the result you want
Would losing the first 10-20 pounds change how you feel in clothes, photos, and everyday life?
One tap starts the private 2-minute plan reveal. No payment to start.
GLP-1 options · Flat pricing · Secure visit ready
GLP-1 treatment is changing how clinicians approach appetite, cravings, and long-term weight loss.


Semaglutide
$99/mo
Single-action GLP-1
Tirzepatide
$149/mo
GIP + GLP-1
Inclusions
Compounded medications are not FDA-approved as finished products. Active ingredients are well-characterized.
The mechanism
Mimic an endogenous incretin
GLP-1 is a hormone your gut produces after eating. GLP-1 receptor agonists are synthetic analogs that bind the same receptors. Semaglutide and tirzepatide have longer half-lives, so a once-weekly injection produces sustained signaling.
Three sites of action
Brain stem and hypothalamus (reduce appetite, increase satiety). Gastric (slow emptying). Pancreatic (improve insulin response to glucose, helpful in diabetes).
Trial outcomes
STEP (semaglutide): mean weight loss 14.9-17.4% over 68 weeks. SURMOUNT (tirzepatide): up to 22.5% over 72 weeks. SELECT (semaglutide CV outcomes): 20% reduction in MACE.
Know what to start with
The right program makes the first month obvious: medication option, protein basics, dose expectations, and a clinician visit before treatment begins.
The information environment
GLP-1 coverage is dominated by people with a position. Pharma marketing, telehealth pages, weight-loss influencers, anti-pharma influencers, finance influencers shorting Lilly. All loud. Most skip the mechanism.
This page gives you the reason why: the receptor, the appetite signal, the trial outcomes, and the flat-rate plan you can check when the evidence lines up.
Social proof with receipts
This is the problem the old diet ads never solved: the food noise, the closet full of clothes that almost fit, the anxiety before photos, and the relief of having a plan that attacks appetite biology instead of asking for more willpower.
12.4K+
patients assessed
4.8
patient rating
15%
semaglutide trial avg
20.9%
tirzepatide high-dose trial avg
Trial figures are from published semaglutide STEP 1 and tirzepatide SURMOUNT-1 data. Individual results vary.
Real momentum, not another restart
Evidence reduces doubt. A doctor signal reduces fear. A clear first month makes the next click rational.
Clinical context
15%
semaglutide avg
20%+
tirzepatide avg
Published trial context. Individual results vary.

Clinician-guided
Your goals and recommended plan are ready before the secure visit opens.

Mei
4 months
-27 lbs

Ethan
6 months
-39 lbs
Individual results vary. Patient stories are representative of common goals people bring to GLP-1 treatment.

“I did not need another pep talk. I needed the hunger to stop running my day.”
Anne T., 52
Verified patient story
47 lbs
7 months

“The biggest change was mental. Food stopped feeling like a negotiation every night.”
Kristina P., 39
Verified patient story
38 lbs
5 months

“I finally felt like my care plan matched the body I actually live in now.”
Linda H., 58
Verified patient story
53 lbs
11 months
I already tried everything.
Exactly. If appetite biology is driving the cycle, another diet is the wrong tool.
I am worried this will feel extreme.
The first step is only a 2-minute quiz. If your answers line up, your plan carries into checkout.
I do not want surprise costs.
Flat monthly pricing, no dose-tier jump, and no insurance maze.
What changes first
People do not start because of a chart alone. They start because they want dinner to end, photos to feel easier, and the next year to look nothing like the last one.
Week 1
Food noise starts feeling less dominant for many patients.
Week 4
Portions, cravings, and late-night eating often become easier to manage.
Month 3
The emotional win is consistency: clothes, photos, energy, and confidence start feeling possible again.
GLP-1s in the news
Public figures helped move GLP-1s out of rumor and into serious public demand.
Oprah, Serena Williams, Whoopi Goldberg, Meghan Trainor, Tracy Morgan, Sharon Osbourne, and others have publicly discussed GLP-1 medications, weight biology, stigma, or treatment experiences.

Serena Williams
Discussed GLP-1 use

Oprah Winfrey
Confirmed medication use

Charles Barkley
Discussed GLP-1 use

Whoopi Goldberg
Discussed GLP-1 use

Jonathan Van Ness
Discussed GLP-1 use

Meghan Trainor
Discussed GLP-1 use

Amy Schumer
Shared her GLP-1 experience

Sharon Osbourne
Discussed her GLP-1
FormScripts not endorsed by these individuals. Celebrity stories are public reporting, not medical advice.
Why GLP-1 care feels different
GLP-1s are talked about for weight loss, but the emotional reason people start is usually deeper: less food noise, fewer failed restart cycles, better appetite control, and a real medical plan.


Plan ready fast
Semaglutide from $99/mo and tirzepatide from $149/mo.
Use this as the plain-English reason to start. Individual results vary, and a licensed clinician makes the prescribing decision.
GLP-1 treatment is best known for helping adults lose weight by changing appetite signaling, not by asking them to white-knuckle another diet.
Many patients describe less mental negotiation around meals, snacks, cravings, and late-night eating once the right plan starts working.
GLP-1 medicines slow gastric emptying and strengthen satiety, so smaller meals can feel more natural.
This medication class started in diabetes care and became a weight-loss breakthrough because appetite, blood sugar, and consistency are connected.
As weight starts moving, many people feel a shift in energy, confidence, clothes, photos, and the way daily routines finally start to stick.
For many people, the win is not only the scale. It is feeling control return around food, photos, clothes, energy, and consistency.
Pricing

Compounded Semaglutide
$99/mo
Single-action GLP-1

Compounded Tirzepatide
$149/mo
Dual-action GIP + GLP-1
Flat monthly price. No dose-tier escalation. Free overnight shipping. Cancel any time. HSA / FSA accepted.
Common questions
Branded medications are FDA-approved finished products. Compounded medications are prepared by U.S.-registered 503A pharmacies for an individual prescription when clinically appropriate. Compounded finished products are not FDA-approved and are not generic versions of brand-name drugs. Your prescribing clinician oversees the pharmacy partner used for your plan.
Yes. If clinically appropriate, compounded semaglutide or tirzepatide is prepared by a U.S.-registered pharmacy under your prescribing clinician's direction. Compounded medications are not FDA-approved finished products and are not reviewed by the FDA for safety or efficacy.
No. FormScripts is a cash-pay program. The flat $99 (semaglutide) or $149 (tirzepatide) per month includes your provider visit, the medication, and shipping. HSA and FSA cards are accepted at checkout.
The quiz shows your GLP-1 option first. If you continue, the secure visit opens with your plan ready.
Yes, any time, from your member portal. No phone gauntlet. No retention reps trying to talk you out of it.
Now decide
Plan ready · HIPAA-protected · Operated by Recess RX LLC
GLP-1s in the news
Major outlets have covered branded GLP-1 medications, semaglutide, and tirzepatide for a reason: people want a medical answer after years of diets that did not hold.
Covered by

Serena Williams
Discussed GLP-1 use
Spoke about GLP-1 care after pregnancy-related weight plateaus.
Source: Vogue

Oprah Winfrey
Confirmed medication use
Reframed weight-loss medication as a medical tool, not a willpower confession.
Source: ABC News

Charles Barkley
Discussed GLP-1 use
Publicly discussed major weight loss after starting a GLP-1.
Source: Healthline

Whoopi Goldberg
Discussed GLP-1 use
Spoke about using medical help and pushed back on public judgment.
Source: E! News

Jonathan Van Ness
Discussed GLP-1 use
Connected GLP-1 care with body-neutral health decisions.
Source: E! News

Meghan Trainor
Discussed GLP-1 use
Said medication was paired with nutrition, training, and lifestyle changes.
Source: E! News

Amy Schumer
Shared her GLP-1 experience
Her story shows why dose, follow-up, and a clear plan cannot be afterthoughts.
Source: Healthline

Sharon Osbourne
Discussed her GLP-1
Said she stopped after losing more weight than she wanted.
Source: Healthline

Chelsea Handler
Discussed semaglutide
Said she was prescribed semaglutide without realizing the specific brand.
Source: Fox News

Lottie Moss
Unsafe-use warning
Warned publicly about hospitalization after inappropriate GLP-1 use.
Source: Telecinco

Tracy Morgan
Discussed his GLP-1
Spoke about his GLP-1 use and the reality that habits still matter.
Source: Us Weekly

Elon Musk
Referenced GLP-1 medications
Helped move GLP-1s from private rumor into public demand.
Source: Axios

Kelly Osbourne
Denied personal use
Denied personal use while defending appropriate medication access.
Source: Hindustan Times
FormScripts not endorsed by these individuals.
The pattern is not fame. It is the same private problem millions of people want solved.
GLP-1 medications can quiet food noise, reduce appetite, and help drive weight loss for the right patient. The first step is a 2-minute quiz that gets your plan ready before checkout.
Celebrity stories are public reporting. Final treatment eligibility is determined by a licensed clinician. Compounded medications are not FDA-approved.
2 minutes · no payment to start